These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2156636)

  • 1. Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart disease.
    Kahn NN; Mueller HS; Sinha AK
    Circ Res; 1990 Apr; 66(4):932-40. PubMed ID: 2156636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration by insulin of impaired prostaglandin E1/I2 receptor activity of platelets in acute ischemic heart disease.
    Kahn NN; Mueller HS; Sinha AK
    Circ Res; 1991 Jan; 68(1):245-54. PubMed ID: 1845854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury.
    Kahn N; Sinha A; Bauman W
    Clin Physiol; 2001 Jan; 21(1):60-6. PubMed ID: 11168298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of high-affinity prostacyclin receptors in platelets and the lack of prostaglandin-induced inhibition of platelet-stimulated thrombin generation in subjects with spinal cord injury.
    Kahn NN; Bauman WA; Sinha AK
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):245-9. PubMed ID: 8552614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet prostacyclin binding in coronary artery disease.
    Jaschonek K; Karsch KR; Weisenberger H; Tidow S; Faul C; Renn W
    J Am Coll Cardiol; 1986 Aug; 8(2):259-66. PubMed ID: 3016061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of a novel circulating anti-prostacyclin receptor antibody.
    Kahn NN; Bauman WA; Sinha AK
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8779-82. PubMed ID: 9238054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets.
    Dutta-Roy AK; Sinha AK
    J Biol Chem; 1987 Sep; 262(26):12685-91. PubMed ID: 2887571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
    Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
    J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans.
    Kahn NN; Bauman WA; Hatcher VB; Sinha AK
    Am J Physiol; 1993 Dec; 265(6 Pt 2):H2160-7. PubMed ID: 8285255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
    Cooper B; Ahern D
    J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of receptors for prostaglandin E1/prostacyclin and insulin in human erythrocytes and platelets.
    Dutta-Roy AK; Kahn NN; Sinha AK
    Life Sci; 1991; 49(16):1129-39. PubMed ID: 1654491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
    Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
    Eggerman TL; Andersen NH; Robertson RP
    J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction.
    Dorn GW; Liel N; Trask JL; Mais DE; Assey ME; Halushka PV
    Circulation; 1990 Jan; 81(1):212-8. PubMed ID: 2137044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1988 Oct; 972(1):45-53. PubMed ID: 2902882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
    Hall JM; Strange PG
    Biosci Rep; 1984 Nov; 4(11):941-8. PubMed ID: 6084527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.